A Drug Interaction Study of Danicopan

Study Identifier:
ACH471-017
ClinicalTrials.gov Identifier:
NCT04709094
EudraCT Identifier:
N/A
Sponsor:
Alexion Pharmaceuticals, Inc.
Study Contact Information:
N/A
Study Complete

Study Details

Medical Condition
  • Other
Study Drug
  • Drug: Danicopan
  • Drug: Warfarin
  • Drug: Bupropion
  • Drug: Ethinyl Estradiol/Norethindrone
Date
Jul 2019 - Oct 2019
Phase 1
Phase 2
Phase 3
Phase 4
N/A
Patient Requirements
Sex: Female & Male
Age: 18 - 65 Years
Requirements Information
Sex
Female & Male
Age
18 - 65 Years

Study Details

Medical Condition
  • Other
Study Drug
  • Drug: Danicopan
  • Drug: Warfarin
  • Drug: Bupropion
  • Drug: Ethinyl Estradiol/Norethindrone
Date
Jul 2019 - Oct 2019
Phase 1
Phase 2
Phase 3
Phase 4
N/A
Patient Requirements
Sex: Female & Male
Age: 18 - 65 Years years
Requirements Information

Protocol Summary

This was a 3-part study (Part 1, Part 2, Part 3) with each part being an open-label, fixed sequence, 2-period study in healthy adult participants.

Trial Locations

Location
Status
Location
Clinical Study Site
Tempe, Arizona, United States, 85283
Status
N/A